Multiple sclerosis: the recent progress of research and treatment

Hiroyuki Murai, Jun-Ichi Kira

研究成果: ジャーナルへの寄稿評論記事

1 引用 (Scopus)

抄録

In this review, we summarized the recent progress of research and treatment of multiple sclerosis (MS). The immunogenetic study including analyses of HLA polymorphism revealed that there are two distinct subtypes of MS: Asian-type and Western-type. Since MS is a polygenic disease, there must be several susceptible genes other than HLA. A large number of candidate genes are being searched and analyzed for polymorphism. Autoantigens responsible for MS are of great interest. Screening peptide library which bind to MS susceptible genes are expected to provide with new autoantigens. Advance in treatment is also remarkable. Since interferon (IFN)-beta 1b became available, great deal of data concerning IFN beta are accumulated. IFN beta not only reduced clinical exacerbation and MRI brain lesions but also slowed the development of brain atrophy. New treatments include altered peptide ligand therapy and oral tolerization with myelin antigens, which are on the clinical trial. Vaccination with myelin reactive T cells or T cell receptor peptide also attracts a great deal of attention.

元の言語英語
ページ(範囲)1211-1218
ページ数8
ジャーナルNippon rinsho. Japanese journal of clinical medicine
59
発行部数6
出版物ステータス出版済み - 1 1 2001

Fingerprint

Multiple Sclerosis
Research
Interferon-beta
Autoantigens
Myelin Sheath
Genes
Therapeutics
Peptide Library
Immunogenetics
Peptides
Brain
T-Cell Antigen Receptor
Atrophy
Vaccination
Clinical Trials
Ligands
T-Lymphocytes
Antigens

All Science Journal Classification (ASJC) codes

  • Medicine(all)

これを引用

Multiple sclerosis : the recent progress of research and treatment. / Murai, Hiroyuki; Kira, Jun-Ichi.

:: Nippon rinsho. Japanese journal of clinical medicine, 巻 59, 番号 6, 01.01.2001, p. 1211-1218.

研究成果: ジャーナルへの寄稿評論記事

@article{acd5c1df9bb74cba8b42f9a64756d39c,
title = "Multiple sclerosis: the recent progress of research and treatment",
abstract = "In this review, we summarized the recent progress of research and treatment of multiple sclerosis (MS). The immunogenetic study including analyses of HLA polymorphism revealed that there are two distinct subtypes of MS: Asian-type and Western-type. Since MS is a polygenic disease, there must be several susceptible genes other than HLA. A large number of candidate genes are being searched and analyzed for polymorphism. Autoantigens responsible for MS are of great interest. Screening peptide library which bind to MS susceptible genes are expected to provide with new autoantigens. Advance in treatment is also remarkable. Since interferon (IFN)-beta 1b became available, great deal of data concerning IFN beta are accumulated. IFN beta not only reduced clinical exacerbation and MRI brain lesions but also slowed the development of brain atrophy. New treatments include altered peptide ligand therapy and oral tolerization with myelin antigens, which are on the clinical trial. Vaccination with myelin reactive T cells or T cell receptor peptide also attracts a great deal of attention.",
author = "Hiroyuki Murai and Jun-Ichi Kira",
year = "2001",
month = "1",
day = "1",
language = "English",
volume = "59",
pages = "1211--1218",
journal = "Astrophysical Journal",
issn = "0004-637X",
publisher = "IOP Publishing Ltd.",
number = "6",

}

TY - JOUR

T1 - Multiple sclerosis

T2 - the recent progress of research and treatment

AU - Murai, Hiroyuki

AU - Kira, Jun-Ichi

PY - 2001/1/1

Y1 - 2001/1/1

N2 - In this review, we summarized the recent progress of research and treatment of multiple sclerosis (MS). The immunogenetic study including analyses of HLA polymorphism revealed that there are two distinct subtypes of MS: Asian-type and Western-type. Since MS is a polygenic disease, there must be several susceptible genes other than HLA. A large number of candidate genes are being searched and analyzed for polymorphism. Autoantigens responsible for MS are of great interest. Screening peptide library which bind to MS susceptible genes are expected to provide with new autoantigens. Advance in treatment is also remarkable. Since interferon (IFN)-beta 1b became available, great deal of data concerning IFN beta are accumulated. IFN beta not only reduced clinical exacerbation and MRI brain lesions but also slowed the development of brain atrophy. New treatments include altered peptide ligand therapy and oral tolerization with myelin antigens, which are on the clinical trial. Vaccination with myelin reactive T cells or T cell receptor peptide also attracts a great deal of attention.

AB - In this review, we summarized the recent progress of research and treatment of multiple sclerosis (MS). The immunogenetic study including analyses of HLA polymorphism revealed that there are two distinct subtypes of MS: Asian-type and Western-type. Since MS is a polygenic disease, there must be several susceptible genes other than HLA. A large number of candidate genes are being searched and analyzed for polymorphism. Autoantigens responsible for MS are of great interest. Screening peptide library which bind to MS susceptible genes are expected to provide with new autoantigens. Advance in treatment is also remarkable. Since interferon (IFN)-beta 1b became available, great deal of data concerning IFN beta are accumulated. IFN beta not only reduced clinical exacerbation and MRI brain lesions but also slowed the development of brain atrophy. New treatments include altered peptide ligand therapy and oral tolerization with myelin antigens, which are on the clinical trial. Vaccination with myelin reactive T cells or T cell receptor peptide also attracts a great deal of attention.

UR - http://www.scopus.com/inward/record.url?scp=0035380637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035380637&partnerID=8YFLogxK

M3 - Review article

C2 - 11411138

AN - SCOPUS:0035380637

VL - 59

SP - 1211

EP - 1218

JO - Astrophysical Journal

JF - Astrophysical Journal

SN - 0004-637X

IS - 6

ER -